Our results reveal abundant PIM3 expression in all BP-NENs, but surprisingly, no higher expression was found in highly aggressive neuroendocrine cancers compared with less aggressive carcinoids. This evidence concerns the gene PIM3 and neuroendocrine carcinoma.